Endocrine MediaSite

The presentation reviewed the University of Michigan’s retrospective experience using pembrolizumab for metastatic adrenocortical carcinoma over five years, treating 25 patients, most of whom were white women…

Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Evaluating the Response of Immunotherapy in Metastatic Adrenocortical Carcinoma - A Single Institution Retrospective Review

Presentations in This Video

Evaluating the Response of Immunotherapy in Metastatic Adrenocortical Carcinoma - A Single Institution Retrospective Review

Katherine Ilona Wolf, MD

UNIVERSITY OF MICHIGAN

Related Media